Abstract

11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) catalyzes the interconversion of cortisone and cortisol within the endoplasmic reticulum. 11β-HSD1 is expressed widely, most notably in the liver, adipose tissue, and central nervous system. It has been studied intensely over the last 10 years because its activity is reported to be increased in visceral adipose tissue of obese people. Epidermal keratinocytes and dermal fibroblasts also express 11β-HSD1. However, the function of the enzymatic activity 11β-HSD1 in skin is not known. We found that 11β-HSD1 was expressed in human and murine epidermis, and this expression increased as keratinocytes differentiate. The expression of 11β-HSD1 by normal human epidermal keratinocytes (NHEKs) was increased by starvation or calcium-induced differentiation in vitro. A selective inhibitor of 11β-HSD1 promoted proliferation of NHEKs and normal human dermal fibroblasts, but did not alter the differentiation of NHEKs. Topical application of selective 11β-HSD1 inhibitor to the dorsal skin of hairless mice caused proliferation of keratinocytes. Taken together, these data suggest that 11β-HSD1 is involved in tissue remodeling of the skin. This hypothesis was further supported by the observation that topical application of the selective 11β-HSD1 inhibitor enhanced cutaneous wound healing in C57BL/6 mice and ob/ob mice. Collectively, we conclude that 11β-HSD1 is negatively regulating the proliferation of keratinocytes and fibroblasts, and cutaneous wound healing. Hence, 11β-HSD1 might maintain skin homeostasis by regulating the proliferation of keratinocytes and dermal fibroblasts. Thus 11β-HSD1 is a novel candidate target for the design of skin disease treatments.

Highlights

  • The endogenous steroid hormone glucocorticoid (GC) is released in response to various stressors such as physical injury and psychological stress

  • The present study shows that 11b-HSD1 is a regulator of keratinocyte and fibroblast proliferation

  • We found that the expression of 11b-HSD1 is higher in the cytoplasm of supra-basal differentiating cells than in basal proliferating cells of the normal epidermis, and that the inhibition of 11b-HSD1 increases the proliferation of keratinocytes and fibroblasts

Read more

Summary

Introduction

The endogenous steroid hormone glucocorticoid (GC) is released in response to various stressors such as physical injury and psychological stress It regulates biological processes including growth, development, metabolism, and behavior [1,2]. The enzyme 11bhydroxysteroid dehydrogenase (11b-HSD) is known to catalyze the interconversion between hormonally active cortisol and inactive cortisone in cells [6,7,8]. Cirillo et al demonstrated enzymatic activity of 11b-HSDs in keratinocyte in culture [17] While these results suggested that 11b-HSDs have functions in skin component cells, the in vivo functions of 11bHSDs, in skin homeostasis remained unclear. We show the effect of topical application of a selective inhibitor of 11b-HSD1 on mouse skin and cutaneous wound healing, which collectively may demonstrate the possibility of 11b-HSD1 as a novel target in treating cutaneous disease

Materials and Methods
Results
Findings
Discussion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.